NOTICE: The popular heartburn drug Zantac has recently been reported to contain elevated levels of a chemical that could cause cancer.
Helping Thousands of Victims Nationwide.
Zantac Lawsuits
Have you Used Zantac, Zantac OTC or Generic Ranitidine and been diagnosed with cancer? Call now or fill out the form for a free case evaluation.
Have you or a loved one been diagnosed with cancer after using Zantac, Zantac OTC or Generic Ranitidine?
You may be eligible for the Zantac Cancer Settlement
The popular heartburn drug Zantac has recently been reported to contain elevated levels of a chemical that could cause cancer. The levels of the chemical N-nitrosodimethylamine (NDMA), a known human carcinogen (cancer-causing substance) found in this drug, have been tested to be anywhere from 3,000 to 26,000 times higher than the legal limit set by the Food and Drug Administration.
In late October 2019, Sanofi issued a voluntary recall of all Zantac OTC (over-the-counter) tablets, which includes Zantac 150, Zantac 150 Cool Mint, and Zantac 75, in light of the FDA’s findings. Since late September 2019, several generic ranitidine medications, including OTC and prescription drugs, have also been recalled. Check out the FDA’s website for the latest recall information
Now, users may be able to file a Zantac lawsuit if they are diagnosed with:
- Bladder Cancer
- Kidney Cancer
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Esophageal/Throat/Nasal Cancer
- Prostate Cancer
- Stomach Cancer
No Fees, Unless Recovery
Free Claim Review
We help you seek Justice & Compensation Due.
What is Zantac?
Zantac, the brand name for ranitidine, is an H2 receptor antagonist (H2 blocker) used to treat conditions like heartburn, acid indigestion, ulcers, and GERD by reducing stomach acid production. The molecular structure of ranitidine includes a nitrite and a DMA group. These components can react together to form NDMA, a substance that the FDA identifies as a probable human carcinogen. Essentially, this means that ranitidine can produce NDMA through its internal chemical reactions, exposing individuals to NDMA with every dose, which may increase their risk of cancer.
Is Zantac still on the market?
The FDA recalled all Zantac products on April 1, 2020. Before this, Zantac was available as both a prescription and an over-the-counter medication, in both branded and generic forms. Here is a brief timeline of Zantac and its generic counterpart, ranitidine:
Brand (Zantac) v. Generic (ranitidine)
- In 1983, the FDA approved Zantac as a prescription medication.
- By 1995, Zantac was approved for over-the-counter sale.
- In 1997, a generic version of the prescription, called ranitidine, was introduced to the market.